Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 3 4Phase 1/2 2Phase NA 1Phase 2/3 1Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 15Carcinoma, Hepatocellular 9Stomach Neoplasms 8Rectal Neoplasms 7Colorectal Neoplasms 7Carcinoma, Non-Small-Cell Lung 7Neoplasms 6Neoplasm Metastasis 6Ovarian Neoplasms 5Brain Neoplasms 5Thyroid Neoplasms 4Sarcoma 4Recurrence 4Urinary Bladder Neoplasms 3Pilonidal Sinus 3Pancreatic Neoplasms 3Neoplastic Cells, Circulating 3Melanoma 3Lung Neoplasms 3Kidney Neoplasms 3Glioblastoma 3Uterine Cervical Neoplasms 2Prostatic Neoplasms 2Peritoneal Neoplasms 2Pain, Postoperative 2Pain 2Oropharyngeal Neoplasms 2Oligodendroglioma 2Liver Neoplasms 2Gastrointestinal Stromal Tumors 2

Interventions

Radiotherapy 8camrelizumab 3Drug Therapy 3Cisplatin 3sintilimab 2Paclitaxel 2Neoadjuvant Therapy 2toripalimab 1tislelizumab 1pembrolizumab 1durvalumab 1anlotinib 1Surgical Procedures, Operative 1Radiofrequency Ablation 1Radiation 1Poly(ADP-ribose) Polymerase Inhibitors 1Observation 1Narrow Band Imaging 1Magnetic Resonance Spectroscopy 1Laparoscopy 1Immune Checkpoint Inhibitors 1Gene Expression Profiling 1Fluorouracil 1Fluorodeoxyglucose F18 1Esophagectomy 1Endoscopy, Digestive System 1Docetaxel 1Consolidation Chemotherapy 1Chemoradiotherapy 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Esophageal Squamous Cell Carcinoma × Surgical Procedures, Operative × Clear all
NCT06762158 2025-01-07

NCRT Combined With Sequential Perioperative PD-1 Inhibitor for LAESCC

RenJi Hospital

Phase NA Active not recruiting
50 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡